Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2-positive Metastatic Breast Cancer × atezolizumab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 26 Lung Neoplasms 20 Carcinoma, Hepatocellular 19 Small Cell Lung Carcinoma 17 Neoplasms 11 Colorectal Neoplasms 8 Urinary Bladder Neoplasms 7 Neoplasm Metastasis 7 Carcinoma, Transitional Cell 7 Carcinoma, Renal Cell 7 Breast Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 5 Melanoma 5 Triple Negative Breast Neoplasms 4 Stomach Neoplasms 4 Ovarian Neoplasms 4 Uterine Cervical Neoplasms 3 Recurrence 3 Pancreatic Neoplasms 3 Liver Neoplasms 3 Carcinoma, Neuroendocrine 3 Solid Tumors 2 Sarcoma, Alveolar Soft Part 2 Sarcoma 2 Prostatic Neoplasms 2 Osteosarcoma 2 Oropharyngeal Neoplasms 2 Nasopharyngeal Carcinoma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Lymphocytic, Chronic, B-Cell 2

Interventions

tucatinib 1 Fulvestrant 1 Alpelisib 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡